An epiretinal membrane will not go away on its own. Once this thin layer of scar-like tissue forms on the surface of your retina, it stays there permanently. The good news is that most epiretinal membranes remain mild and never need treatment. In a long-term study tracking eyes with good starting vision (20/40 or better), only about 21% required surgery after four years, meaning roughly 4 out of 5 people were able to live with theirs.
What an Epiretinal Membrane Actually Is
An epiretinal membrane is a paper-thin sheet of fibrous tissue that grows across the macula, the central part of your retina responsible for sharp, detailed vision. It forms when certain cells migrate to the retinal surface and transform into fibroblast-like cells that produce a translucent film. In its earliest stage, you might hear it called “cellophane maculopathy” because of how thin it looks on exam.
The trigger in about 95% of cases is posterior vitreous detachment, a common age-related event where the gel inside your eye separates from the retina. This separation creates tiny breaks in the retina’s inner surface layer, allowing cells to slip through and start building the membrane. Because vitreous detachment becomes increasingly common after age 50, epiretinal membranes are overwhelmingly a condition of aging. Less commonly, they form after eye surgery, retinal tears, inflammation, or injury.
How It Changes Over Time Without Treatment
Most epiretinal membranes progress very slowly. In eyes starting with 20/40 vision or better, visual acuity declined at a rate of roughly one letter on an eye chart per year. At that pace, many people go years without noticing a meaningful change.
The membrane itself doesn’t shrink or dissolve, but it doesn’t always tighten either. Some stay flat and thin indefinitely. Others gradually contract, pulling on the retina and creating wrinkles or folds in the macula. That contraction is what causes the hallmark symptom: metamorphopsia, where straight lines look wavy or distorted. You might also notice mild blurriness or a sense that things look slightly different between your two eyes. The progression from a flat, barely noticeable membrane to one causing real visual symptoms can take years, and in many cases it never happens at all.
When Surgery Becomes the Right Call
Doctors typically recommend surgery when your vision drops below 20/30 and the membrane is clearly responsible, or when you develop noticeable distortion that interferes with daily activities like reading and driving. If your vision is 20/30 or better at diagnosis, observation is usually the first approach, unless you’re already experiencing moderate distortion. A drop of more than one line on the eye chart, combined with changes visible on an OCT scan showing the membrane is progressing, generally tips the decision toward surgery.
There’s a practical reason behind the 20/30 threshold: the difficulty of everyday tasks like reading, cooking, and managing finances roughly doubles between 20/25 and 20/32. Waiting too long carries its own risks. Prolonged traction on the retina can cause fluid buildup (cystoid macular edema) and structural damage that may not fully reverse even after the membrane is removed.
What Surgery Involves and How Well It Works
The procedure is called a vitrectomy with membrane peel. A retinal surgeon removes the vitreous gel from inside the eye, then carefully peels the membrane off the retinal surface using microsurgical instruments. It’s typically done as an outpatient procedure under local anesthesia.
Results are generally good. In one study of eyes starting with 20/50 or better vision, the average improved from 20/40 before surgery to 20/28 at one year. About 73% of patients reported noticeable improvement in their visual symptoms. Recovery speed varies quite a bit from person to person. Some people see improvement within the first month. Others don’t notice meaningful gains until three to six months after surgery, particularly those whose retina had more swelling beforehand.
Risks and Tradeoffs of Surgery
The most predictable side effect is cataract formation. If you still have your natural lens, there’s roughly an 80% chance you’ll develop a visually significant cataract within two years of vitrectomy. Many surgeons discuss combining cataract surgery with the membrane peel, or planning for it shortly after.
Membrane recurrence is the other notable risk. About 30% of eyes show some residual or regrown membrane tissue on follow-up scans. Most of these remnants are small and don’t cover the central macula, so they don’t affect vision. Foveal recurrence, where the membrane grows back over the center of your vision, occurs in roughly 8% of cases. Reoperation is ultimately needed in about 4% of patients. Eyes where a visible membrane remnant is left at the edge of the surgical site have a higher chance of regrowth.
How Doctors Track Your Membrane
Optical coherence tomography (OCT), a painless scan that creates cross-sectional images of your retina, is the main tool for monitoring. It reveals things you can’t feel yet: whether the membrane is pulling the retina’s normal contour out of shape, whether fluid is accumulating in the retinal layers, and whether the delicate cell layers responsible for your sharpest vision are still intact.
Doctors use a four-stage classification based on these scans. Stage 1 membranes sit on top of a retina that still looks essentially normal, with the central foveal dip preserved and all layers clearly visible. By stage 4, the foveal dip is gone and the retinal layers beneath the membrane are so disrupted they can’t be individually identified. Higher stages at the time of surgery are associated with less visual recovery afterward, which is one reason doctors monitor regularly rather than simply waiting for symptoms to worsen.
If you’ve been diagnosed with an epiretinal membrane and your vision is still good, the most likely outcome is that it stays manageable for years. Regular OCT monitoring, typically every 6 to 12 months, lets your doctor catch progression early enough to intervene before permanent retinal changes set in.